GREPIC

What GREPIC does

GREPIC (Groupement Régional des Etablissements Pharmaceutiques Industriels du Centre) is a French non-profit regional industry association founded in 1980 and headquartered at 16 rue de la Vallée Maillard, 41018 Blois Cedex. It federates approximately 47 pharmaceutical production sites in the Centre-Val de Loire region, including pharmaceutical laboratories, contract manufacturers (CDMOs), logistics providers, training institutions, and institutional members, collectively representing around 8,000 pharmaceutical production jobs — roughly 10% of France's national pharmaceutical workforce. The Centre-Val de Loire region ranks as France's 3rd largest pharmaceutical production region, producing more than 1.5 billion boxes of medicines annually and generating €4.8 billion in pharmaceutical exports (23% of total regional exports, 85% to Europe).

The association operates through eight specialized commissions covering HR, Production, Quality, HSE, Maintenance, Supply Chain, Purchasing, and Operational Excellence, each typically hosting 3-4 sessions per year at member sites. These commissions function as peer benchmarking and best-practice exchange forums. GREPIC also coordinates workforce development through partnerships with Groupe IMT (8 campuses, 5,000 trainees/year), Université de Tours, and Polytech Orléans, and supports bioproduction transition via the Fondation Philippe-Maupas (created June 2013) and the Bio3 Institute (a 2,500 m² GMP-like training facility). GREPIC does not sell products or own proprietary technology; it facilitates knowledge transfer, regulatory navigation, Industry 4.0 adoption, and collective advocacy. Distribution of services occurs through commission sessions, site visits, the Grepic News newsletter, the grepic.org website, LinkedIn, annual industry events such as the Semaine des Métiers de l'Industrie Pharmaceutique, and inter-regional cooperation with peer clusters coordinated by Leem.

Revenue mechanics are membership-based: GREPIC is an association under French law (Loi 1901, SIREN 387 897 820), funded by membership contributions from its 47 member establishments. The association maintains a lean operational footprint of 1-10 staff (essentially a mission manager plus minimal administrative support), with members serving simultaneously as customers and stakeholders. The current president is Christophe Roberge (elected September 2024), who also serves as Industrial Director of Ethypharm.

Name

GREPIC

Legal name

Association GREPIC

Website

https://grepic.org

Company type

Private

Founded year

1980

Operating status

Operating

Headcount range

1–10 employees

Short description

GREPIC is a French non-profit regional industry association founded in 1980 that federates 47 pharmaceutical production sites in Centre-Val de Loire — laboratories, CDMOs, logistics providers, training institutions — collectively representing around 8,000 jobs or 10% of France's pharmaceutical workforce.

Ownership category

akta.pro rank

Headquarters

HQ city

Blois

HQ country

France

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Others

Revenue model

1. Membership contributions: GREPIC operates as a non-profit association funded by membership fees from its 47 pharmaceutical and cosmetics production sites, contractors, institutional members, and training institutions in Centre-Val de Loire.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels7 records

Core offering

GREPIC is a regional pharmaceutical industry association (cluster) that federates approximately 47 pharmaceutical production sites, CDMOs, logistics providers, training institutions, and institutional members in the Centre-Val de Loire region of France. It provides peer benchmarking, best-practice exchange, training support, innovation support, and collective advocacy through 8 specialized commissions (RH, Production, Quality, HSE, Maintenance, Supply Chain, Purchasing, Operational Excellence). The association operates as a non-profit under French law (Loi 1901), funded by membership contributions.

Product overview

GREPIC (Groupement Régional des Etablissements Pharmaceutiques Industriels du Centre) is a regional industry association that brings together pharmaceutical production sites and related organizations in Centre-Val de Loire, France. It does not offer products for sale. Its activities center on eight industrial commissions (Production, Supply Chain, Quality, HSE, Maintenance, Operational Excellence, Purchasing, and HR) that facilitate benchmarking, best-practice sharing, and peer collaboration among approximately 47 member sites. The association also supports training through the Groupe IMT, supports innovation and biomedicines via the Fondation Philippe-Maupas and Bio3 Institute, and organizes workforce development initiatives such as the Semaine des métiers de l'industrie pharmaceutique.

Differentiator

Problem solved

Functional benefit

Products and services

• GREPIC Membership Annual membership for pharmaceutical production sites, CDMOs, contractors, institutional members, and training institutions in Centre-Val de Loire. Provides access to 8 specialized commissions, peer benchmarking, best-practice exchange, training support, innovation support, and collective advocacy. Currently 47 member sites representing ~8,000 pharmaceutical production jobs.
• GREPIC Specialized Commissions (8 commissions) Eight functional commissions covering Achats (Purchasing), Supply Chain, Production, HSE, Assurance Qualité, Ressources Humaines, Maintenance, and Excellence Opérationnelle. Each commission organizes 3-4 sessions per year hosted at member production sites, enabling peer-to-peer learning and best-practice benchmarking.
• Training Support Programs (Soutien à la formation) GREPIC serves as the natural partner for academic and professional training organizations in Centre-Val de Loire, including Université de Tours, Faculté des Sciences Pharmaceutiques, Université d'Orléans, Réseau Polytech, and Groupe IMT. Facilitates workforce development, curriculum co-design, apprenticeship programs, and industry-immersion events.

Quantifiable outcome

• 47 member sites federated, representing ~8,000 pharmaceutical production jobs (~10% of France's pharmaceutical workforce)
• +5 more outcomes

Named customers36 records

Segments3 records

Ideal customer profiles3 records

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

19 partnerships are on record, tiered core and minor.

• Fondation Partenariale Philippe-MaupascoreStrategic or Co-development Partner · 20 June 2013GREPIC chairs the Fondation Partenariale Philippe-Maupas, created on 20 June 2013 to facilitate private fundraising for developing bioproduction in Centre-Val de Loire and France. The Foundation supports the Bio3 Institute (training center for bioproduction), R&D programs at Université de Tours, and events promoting the biomedicines ecosystem. It has 25 founding members/donors including pharmaceutical companies, universities, and industry partners.
• Bio3 InstitutecoreStrategic or Co-development PartnerThe Bio3 Institute, co-managed by Université de Tours and Groupe IMT, is the first project financed by public and private funds to create a reference center for bioproduction training. Located on a 2,500 m² state-of-the-art platform simulating a mini bioproduction plant in GMP-like conditions, it provides initial and continuing training, supports research teams (start-ups, industrials, academics), and offers industrial equipment for production trials.
• LabEx MAbImproveminorStrategic or Co-development PartnerLabEx MAbImprove brings together research laboratories from Université de Tours and Montpellier focused on therapeutic monoclonal antibodies, supporting innovation in biomedicines within the GREPIC ecosystem.
• Leem (Les Entreprises du Médicament)coreStrategic or Co-development PartnerLeem is the French pharmaceutical industry professional organization representing 260+ companies and ~100,000 employees. GREPIC works closely with Leem on industry promotion (Semaine des Métiers), regulatory advocacy, social and HR policy, and inter-groupement coordination. Leem provides national-level expertise, legal/regulatory updates, and institutional representation that GREPIC members benefit from.
• PolepharmacoreStrategic or Co-development PartnerPolepharma is the first European pharmaceutical industrial cooperation, structuring the French (bio)pharmaceutical sector for 20 years. With 400+ members, €26B export revenue, and 80,000 employees across France, it drives the sector's transformation and industrial sovereignty. GREPIC is a regional partner of Polepharma within the Centre-Val de Loire ecosystem.
• Université de Tours / Faculté de Pharmacie Philippe-MaupascoreStrategic or Co-development PartnerGREPIC has a partnership convention with the Faculty of Pharmacy Philippe-Maupas de Tours. GREPIC supports pharmaceutical industry careers promotion, student immersion, and curriculum alignment. The partnership includes the Commission Industrie that meets regularly to strengthen links between industry and academia. GREPIC donated €15,000 to the Philippe-Maupas Foundation to support its 5-year continuation.
• Groupe IMTcoreStrategic or Co-development PartnerCreated in 1980 at the initiative of GREPIC members, Groupe IMT is the French leader in training for pharmaceutical, biotechnology, cosmetics, and dietetic industry professions. With 8 campuses and GMP-like technical platforms, it trains 5,000 people per year. IMT campuses are located in Tours, Évry, Val-de-Reuil, Dreux, Dijon, Lyon, Lille (and soon Toulouse).
• Polytech Orléans / Chartres CampusminorStrategic or Co-development PartnerGREPIC collaborated with Polytech Orléans to define the engineering curriculum for 'Génie Industriel pour la cosmétique, la pharmacie et l'agro-alimentaire' (Industrial Engineering for cosmetics, pharma, and agrifood). The program is accessible via student or apprenticeship routes, connecting engineers with real industry needs.
• Université d'OrléansminorStrategic or Co-development PartnerUniversité d'Orléans is part of GREPIC's training ecosystem, contributing to workforce development and academic-industry collaboration in the Centre-Val de Loire pharmaceutical region.
• Région Centre-Val de LoireminorStrategic or Co-development PartnerThe regional council supports GREPIC's ecosystem development initiatives, particularly around bioproduction and the pharmaceutical industry's role in the region's economic development.
• InterPharma ToursminorStrategic or Co-development PartnerAssociation of industrial pharmacy students at Université de Tours. GREPIC collaborates with InterPharma Tours for career events, student-industry encounters, and promotion of pharmaceutical industry professions among future pharmacists.
• AfipralminorStrategic or Co-development PartnerRegional pharmaceutical industry group based in Lyon (Auvergne-Rhône-Alpes). GREPIC participates in inter-groupement meetings with Afipral, GIMRA, Allis-NA, and Santénov, coordinated by Leem, to share best practices and coordinate industry promotion activities.
• GIMRAminorStrategic or Co-development PartnerRegional pharmaceutical industry group in Auvergne. GREPIC participates in inter-groupement meetings with GIMRA, coordinated by Leem.
• SanténovminorStrategic or Co-development PartnerRegional pharmaceutical industry group in Nouvelle-Aquitaine. GREPIC participates in inter-groupement meetings coordinated by Leem.
• Allis-NAminorStrategic or Co-development PartnerRegional pharmaceutical industry group. GREPIC participates in inter-groupement meetings coordinated by Leem.
• Pôle emploiminorImplementation/ SI/ Consulting PartnerFrench public employment service. GREPIC collaborates with Pôle emploi on the Semaine des Métiers de l'Industrie Pharmaceutique (national pharmaceutical careers week) to promote job opportunities at member sites and facilitate recruitment.
• Opco 2iminorImplementation/ SI/ Consulting PartnerFrench skills development operator for industrial sectors. Works with GREPIC and Leem on training programs, apprenticeships, and professional development for pharmaceutical industry workers.
• HandiEMminorStrategic or Co-development PartnerOrganization promoting employment of people with disabilities in the pharmaceutical industry. GREPIC partners with HandiEM during the Semaine des Métiers to promote inclusive recruitment at member sites.
• France BioLeadminorStrategic or Co-development PartnerNational organization driving bioproduction development. GREPIC supports France BioLead events including the JNBB (Journée Nationale de la Bioproduction et des Biomédicaments) hosted at the Bio3 Institute in Tours.

Scale indicators7 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Santénov: Santénov is the regional pharmaceutical industry group in Nouvelle-Aquitaine. GREPIC participates in inter-groupement meetings coordinated by Leem, sharing the same regional cluster mandate and member-driven model.
• Polepharma: Polepharma is the first European pharmaceutical industrial cooperation body, structuring the French (bio)pharmaceutical sector for 20 years. With 400+ members, €26B export revenue, and 80,000 employees across France, it is the national-level counterpart to GREPIC's regional cluster model. GREPIC is a regional partner of Polepharma within the Centre-Val de Loire ecosystem.
• Afipral: Afipral is the regional pharmaceutical industry group based in Auvergne-Rhône-Alpes (Lyon). GREPIC participates in inter-groupement meetings with Afipral, GIMRA, Allis-NA, and Santénov, coordinated by Leem, to share best practices and coordinate industry promotion activities across regions.
• Allis-NA: Allis-NA is a regional pharmaceutical industry group participating in inter-groupement meetings coordinated by Leem alongside GREPIC, GIMRA, Afipral, and Santénov. It is another regional cluster with which GREPIC directly interacts.
• GIMRA: GIMRA is the regional pharmaceutical industry group in Auvergne. GREPIC participates in inter-groupement meetings with GIMRA and other regional groups, coordinated by Leem, making it a directly comparable regional pharma industry association.

Others

• Fondation Partenariale Philippe-Maupas: GREPIC chairs the Philippe-Maupas Foundation, created in 2013 to facilitate private fundraising for bioproduction development in Centre-Val de Loire and France. The Foundation supports the Bio3 Institute and R&D programs at Université de Tours, making it a closely related entity that GREPIC uses to channel innovation funding.
• Bio3 Institute: The Bio3 Institute, co-managed by Université de Tours and Groupe IMT, is the first reference center for bioproduction training in France. Located on a 2,500 m² GMP-like platform, it is a strategic partner of GREPIC and a partially comparable training/innovation entity serving the same member ecosystem.

Broad incumbents

• Medicen Paris Region: Medicen Paris Region is a competitive cluster dedicated to health, bringing together pharma, biotech, medtech, and digital health players in the Île-de-France region. It is comparable to GREPIC as a regional health/pharma industry cluster, though broader in scope and substantially larger in member companies.
• Leem (Les Entreprises du Médicament): Leem is the French pharmaceutical industry professional organization representing 260+ companies and ~100,000 employees nationwide. GREPIC works closely with Leem on industry promotion, regulatory advocacy, and inter-groupement coordination. Leem is the national industry body that GREPIC's regional association model complements.

Emerging players

• Lyonbiopôle: Lyonbiopôle is a French competitiveness cluster focused on biotechnologies, infectious diseases, and bioproduction. It is comparable to GREPIC's Bio3 Institute and bioproduction-training agenda, sharing a focus on bioproduction ecosystem development and innovation support.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/grepic

Revenue estimate

Valuation estimate

Number of profiles

Profiles13 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about GREPIC